glp-1 delivery Novel plant-based approach to a better, cheaper system Sam's Club announces delivery of

This affordability equation is expected to shift significantly after the patent on Semaglutide expires in China and India in 2026

The GLP-1 conversation is just beginning in Aotearoa and Im excited about the role we can play in supporting long-term health Business desk article: Our GLP-1 Support meals:

Confirmed ginger's role in supporting digestive comfort across multiple clinical contexts

Discover why doctors avoid this combination and explore how personalized tirzepatide therapy offers a proven single-agent approach

In a pediatric population with limited treatment options beyond metformin and insulin, this represents a real therapeutic advancement for an underserved group

Divergence across payer type matters: Commercial patients adopt GLP1s earlier and often remain on monotherapy, while Medicare patients face stricter controls and higher comorbidity burdens